BOCOM INTL: SIMCERE PHARMA (02096) successfully authorized AbbVie for its self-developed blood tumor/autoimmune tri-antibody on the TCE platform, receiving endorsement from the first MNC.

In the future, the company will actively explore the development potential of SIM0500 in the field of autoimmunity with AbbVie.

Zhitong Finance09:54

AbbVie Options Spot-On: On January 14th, 279.67K Contracts Were Traded, With 424.08K Open Interest

On January 14th ET, $AbbVie(ABBV.US)$ had active options trading, with a total trading volume of 279.67K options for the day, of which put options accounted for 2.31% of the total transactions, and

Futu News05:30

The Momentum Factor ETF Is Coming off a Great 2024 but Still Oversold

Seeking Alpha03:01

AbbVie Inc. (ABBV): An Undervalued Dividend Kings Stock to Invest in Now?

Yahoo Finance02:38

10 Health Care Stocks With Whale Alerts In Today's Session

Benzinga01:35

AbbVie Falls 8% in 3 Months: Buy, Hold or Sell the Stock?

Zacks Jan 14 23:35